...
首页> 外文期刊>Journal of molecular recognition: JMR >Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG-CoA reductase.
【24h】

Modeling an active conformation for linear peptides and design of a competitive inhibitor for HMG-CoA reductase.

机译:对线性肽的活性构象进行建模,并设计HMG-CoA还原酶的竞争性抑制剂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study presents an approach that can be used to search for lead peptide candidates, including unconstrained structures in a recognized sequence. This approach was performed using the design of a competitive inhibitor for 3-hydroxy-3-methylglutaryl CoA reductase (HMGR). In a previous design for constrained peptides, a head-to-tail cyclic structure of peptide was used as a model of linear analog in searches for lead peptides with a structure close to an active conformation. Analysis of the conformational space occupied by the peptides suggests that an analogical approach can be applied for finding a lead peptide with an unconstrained structure in a recognized sequence via modeling a cycle using fixed residues of the peptide backbone. Using the space obtained by an analysis of the bioactive conformations of statins, eight cyclic peptides were selected for a peptide library based on the YVAE sequence as a recognized motif. For each cycle, the four models were assessed according to the design criterion ("V" parameter) applied for constrained peptides. Three cyclic peptides (FGYVAE, FPYVAE, and FFYVAE) were selected as lead cycles from the library. The linear FGYVAE peptide (IC(50) = 0.4 microM) showed a 1200-fold increase the inhibitory activity compared to the first isolated LPYP peptide (IC(50) = 484 microM) from soybean. Experimental analysis of the modeled peptide structures confirms the appropriateness of the proposed approach for the modeling of active conformations of peptides.
机译:这项研究提出了一种可用于搜索候选先导肽的方法,包括在公认序列中不受约束的结构。该方法是使用3-羟基-3-甲基戊二酰辅酶A还原酶(HMGR)竞争性抑制剂的设计进行的。在以前的约束肽设计中,肽的头尾环结构被用作线性类似物的模型,以寻找结构接近活性构象的前导肽。对肽所占据的构象空间的分析表明,通过使用肽主链的固定残基对循环进行建模,可以采用类似的方法来发现识别序列中具有不受约束的结构的前导肽。利用通过分析他汀类药物生物活性构象而获得的空间,基于YVAE序列作为公认的基序,选择了八个环状肽用于肽库。对于每个循环,根据用于约束肽的设计标准(“ V”参数)评估四个模型。从文库中选择了三个环肽(FGYVAE,FPYVAE和FFYVAE)作为前导循环。线性FGYVAE肽(IC(50)= 0.4 microM)与从大豆中分离的第一个LPYP肽(IC(50)= 484 microM)相比,抑制活性提高了1200倍。对建模的肽结构进行的实验分析证实了所提出的方法对肽的活性构象进行建模的适当性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号